Use of research biopsies in clinical trials: Are risks and benefits adequately discussed?

Journal of Clinical Oncology

Volumn 31, Issue 1, 2013, Pages 17-22

  Overman, Michael J ^a   Modak, Janhavi ^a   Kopetz, Scott ^a   Murthy, Ravi ^a   Yao, James C ^a   Hicks, Marshall E ^a   Abbruzzese, James L ^a   Tam, Alda L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOPSY TECHNIQUE; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); DATA EXTRACTION; DIAGNOSTIC PROCEDURE; HEART ATRIUM FIBRILLATION; HEMATOMA; HUMAN; HYPOTENSION; IMAGE GUIDED BIOPSY; INFORMED CONSENT; MAJOR CLINICAL STUDY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RESEARCH BIOPSY; TREATMENT INDICATION; TUMOR BIOPSY;

BIOMEDICAL RESEARCH; BIOPSY; CLINICAL TRIALS AS TOPIC; HUMANS; INFORMED CONSENT; MEDICAL ONCOLOGY; NEOPLASMS; RISK ASSESSMENT;

EID: 84871756952     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.1718     Document Type: Article

References (25)

1. Banerji U, de Bono J, Judson I, et al: Biomarkers in early clinical trials: The committed and the skeptics. Clin Cancer Res 14:2512; author reply 2513-2514, 2008
2. Cannistra SA: Performance of biopsies in clinical research. J Clin Oncol 25:1454-1455, 2007
3. Goulart BH, Clark JW, Pien HH, et al: Trends in the use and role of biomarkers in phase I oncology trials. Clin Cancer Res 13:6719-6726, 2007
4. Helft PR, Daugherty CK: Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation. J Clin Oncol 24:4793-4795, 2006
5. Joffe S, Miller FG: Bench to bedside: Mapping the moral terrain of clinical research. Hastings Cent Rep 38:30-42, 2008
6. Olson EM, Lin NU, Krop IE, et al: The ethical use of mandatory research biopsies. Nat Rev Clin Oncol 8:620-625, 2011
7. Weijer C, Miller PB: When are research risks reasonable in relation to anticipated benefits? Nat Med 10:570-573, 2004
8. Emanuel EJ, Wendler D, Grady C: What makes clinical research ethical? JAMA 283:2701-2711, 2000
9. Anderson BD, Adamson PC, Weiner SL, et al: Tissue collection for correlative studies in childhood cancer clinical trials: Ethical considerations and special imperatives. J Clin Oncol 22:4846-4850, 2004
10. Katz M: Are we asking too much? The challenges of mandatory research biopsies within clinical trials. Presented at the 46th Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, June 4-8, 2010
11. Peppercorn J, Shapira I, Collyar D, et al: Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology. J Clin Oncol 28:2635-2640, 2010
12. Dancey JE, Dobbin KK, Groshen S, et al: Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents. Clin Cancer Res 16:1745-1755, 2010
13. "Criteria for IRB approval of research," 45 Code of Federal Regulations part 46.111(a), 2011
14. Ratain MJ, Glassman RH: Biomarkers in phase I oncology trials: Signal, noise, or expensive distraction? Clin Cancer Res 13:6545-6548, 2007
15. Joffe S, Cook EF, Cleary PD, et al: Quality of informed consent in cancer clinical trials: A cross-sectional survey. Lancet 358:1772-1777, 2001
16. Daugherty C, Ratain MJ, Grochowski E, et al: Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol 13:1062-1072, 1995
17. Kodish E, Stocking C, Ratain MJ, et al: Ethical issues in phase I oncology research: A comparison of investigators and institutional review board chairpersons. J Clin Oncol 10:1810-1816, 1992
18. Lidz CW, Appelbaum PS, Grisso T, et al: Therapeutic misconception and the appreciation of risks in clinical trials. Soc Sci Med 58:1689-1697, 2004
19. Agulnik M, Oza AM, Pond GR, et al: Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents. J Clin Oncol 24:4801-4807, 2006
20. Brown AP, Wendler DS, Camphausen KA, et al: Performing nondiagnostic research biopsies in irradiated tissue: A review of scientific, clinical, and ethical considerations. J Clin Oncol 26:3987-3994, 2008
21. Dowlati A, Haaga J, Remick SC, et al: Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation. Clin Cancer Res 7:2971-2976, 2001
22. Gomez-Roca CA, Lacroix L, Massard C, et al: Sequential research-related biopsies in phase I trials: Acceptance, feasibility and safety. Ann Oncol 23:1301-1306, 2012
23. El-Osta H, Hong D, Wheler J, et al: Outcomes of research biopsies in phase I clinical trials: The MD Anderson Cancer Center experience. Oncologist 16:1292-1298, 2011
24. Covey AM, Gandhi R, Brody LA, et al: Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. J Vasc Interv Radiol 15:479-483, 2004
25. Hiraki T, Mimura H, Gobara H, et al: Incidence of and risk factors for pneumothorax and chest tube placement after CT fluoroscopy-guided percutaneous lung biopsy: Retrospective analysis of the procedures conducted over a 9-year period. AJR Am J Roentgenol 194:809-814, 2010